Two crystal structures of human neutrophil collagenase, one complexed with a primed- and the other with an unprimed-side inhibitor: Implications for drug design

Gavuzzo E, Pochetti G, Mazza F, Gallina C, Gorini B, D'Alessio S, Pieper M, Tschesche H, Tucker PA (2000)
JOURNAL OF MEDICINAL CHEMISTRY 43(18): 3377-3385.

Journal Article | Published | English

No fulltext has been uploaded

Author
; ; ; ; ; ; ; ;
Abstract
Two crystal structures of human neutrophil collagenase (HNC, MMP-8), one complexed with a primed- and the other with an unprimed-side inhibitor, were determined using synchrotron radiation at 100 K. Both inhibitors contain non-hydroxamate zinc-binding functions. The Pro-Leu-L-Trp(P)(OH)(2) occupies the unprimed region of the active site, furnishes new structural information regarding interaction between the catalytic zinc ion and the phosphonate group, and is the only example of occupation of the S-1 subsite of MMP-8 by the bulky tryptophan side chain. The (R)-2-(biphenyl-4-ylsulfonyl)-1,2,3,4-tetrahydroisochinolin-3-carboxylic acid, a conformationally constrained D-Tic derivative, accommodates its biphenyl substituent into the deep primary specificity S-1' subsite, inducing a widening of the entrance to this pocket; this modification of the protein, mainly consisting in a shift of the segment centered at Pro217, is observed for the first time in MMP-8 complexes. Cation-aromatic interactions can stabilize the formation of both complexes, and the beneficial effect of aromatic substituents in proximity of the catalytic zinc ion is discussed. The phosphonate group bound to either a primed- or unprimed-side inhibitor maintains the same relative position with respect to the catalytic zinc ion, suggesting that this binding function can be exploited for the design of combined inhibitors assembled to interact with both primed and unprimed regions of the active cleft.
Publishing Year
ISSN
eISSN
PUB-ID

Cite this

Gavuzzo E, Pochetti G, Mazza F, et al. Two crystal structures of human neutrophil collagenase, one complexed with a primed- and the other with an unprimed-side inhibitor: Implications for drug design. JOURNAL OF MEDICINAL CHEMISTRY. 2000;43(18):3377-3385.
Gavuzzo, E., Pochetti, G., Mazza, F., Gallina, C., Gorini, B., D'Alessio, S., Pieper, M., et al. (2000). Two crystal structures of human neutrophil collagenase, one complexed with a primed- and the other with an unprimed-side inhibitor: Implications for drug design. JOURNAL OF MEDICINAL CHEMISTRY, 43(18), 3377-3385.
Gavuzzo, E., Pochetti, G., Mazza, F., Gallina, C., Gorini, B., D'Alessio, S., Pieper, M., Tschesche, H., and Tucker, P. A. (2000). Two crystal structures of human neutrophil collagenase, one complexed with a primed- and the other with an unprimed-side inhibitor: Implications for drug design. JOURNAL OF MEDICINAL CHEMISTRY 43, 3377-3385.
Gavuzzo, E., et al., 2000. Two crystal structures of human neutrophil collagenase, one complexed with a primed- and the other with an unprimed-side inhibitor: Implications for drug design. JOURNAL OF MEDICINAL CHEMISTRY, 43(18), p 3377-3385.
E. Gavuzzo, et al., “Two crystal structures of human neutrophil collagenase, one complexed with a primed- and the other with an unprimed-side inhibitor: Implications for drug design”, JOURNAL OF MEDICINAL CHEMISTRY, vol. 43, 2000, pp. 3377-3385.
Gavuzzo, E., Pochetti, G., Mazza, F., Gallina, C., Gorini, B., D'Alessio, S., Pieper, M., Tschesche, H., Tucker, P.A.: Two crystal structures of human neutrophil collagenase, one complexed with a primed- and the other with an unprimed-side inhibitor: Implications for drug design. JOURNAL OF MEDICINAL CHEMISTRY. 43, 3377-3385 (2000).
Gavuzzo, E, Pochetti, G, Mazza, F, Gallina, C, Gorini, B, D'Alessio, S, Pieper, M, Tschesche, Harald, and Tucker, PA. “Two crystal structures of human neutrophil collagenase, one complexed with a primed- and the other with an unprimed-side inhibitor: Implications for drug design”. JOURNAL OF MEDICINAL CHEMISTRY 43.18 (2000): 3377-3385.
This data publication is cited in the following publications:
This publication cites the following data publications:

10 Citations in Europe PMC

Data provided by Europe PubMed Central.

Triple-helical transition state analogues: a new class of selective matrix metalloproteinase inhibitors.
Lauer-Fields J, Brew K, Whitehead JK, Li S, Hammer RP, Fields GB., J. Am. Chem. Soc. 129(34), 2007
PMID: 17672455
Molecular dynamics simulation of Leishmania major surface metalloprotease GP63 (leishmanolysin).
Bianchini G, Bocedi A, Ascenzi P, Gavuzzo E, Mazza F, Aschi M., Proteins 64(2), 2006
PMID: 16708363
Insight into autoproteolytic activation from the structure of cephalosporin acylase: a protein with two proteolytic chemistries.
Kim JK, Yang IS, Shin HJ, Cho KJ, Ryu EK, Kim SH, Park SS, Kim KH., Proc. Natl. Acad. Sci. U.S.A. 103(6), 2006
PMID: 16446446
N-Hydroxyurea as zinc binding group in matrix metalloproteinase inhibition: mode of binding in a complex with MMP-8.
Campestre C, Agamennone M, Tortorella P, Preziuso S, Biasone A, Gavuzzo E, Pochetti G, Mazza F, Hiller O, Tschesche H, Consalvi V, Gallina C., Bioorg. Med. Chem. Lett. 16(1), 2006
PMID: 16242329
Design, modelling, synthesis and biological evaluation of peptidomimetic phosphinates as inhibitors of matrix metalloproteinases MMP-2 and MMP-8.
Bianchini G, Aschi M, Cavicchio G, Crucianelli M, Preziuso S, Gallina C, Nastari A, Gavuzzo E, Mazza F., Bioorg. Med. Chem. 13(15), 2005
PMID: 15935680
Future challenges facing the development of specific active-site-directed synthetic inhibitors of MMPs.
Cuniasse P, Devel L, Makaritis A, Beau F, Georgiadis D, Matziari M, Yiotakis A, Dive V., Biochimie 87(3-4), 2005
PMID: 15781327
Structural basis for the highly selective inhibition of MMP-13.
Engel CK, Pirard B, Schimanski S, Kirsch R, Habermann J, Klingler O, Schlotte V, Weithmann KU, Wendt KU., Chem. Biol. 12(2), 2005
PMID: 15734645
Synthesis and evaluation of new tripeptide phosphonate inhibitors of MMP-8 and MMP-2.
Agamennone M, Campestre C, Preziuso S, Consalvi V, Crucianelli M, Mazza F, Politi V, Ragno R, Tortorella P, Gallina C., Eur J Med Chem 40(3), 2005
PMID: 15725496
Crystal structure of the catalytic domain of human matrix metalloproteinase 10.
Bertini I, Calderone V, Fragai M, Luchinat C, Mangani S, Terni B., J. Mol. Biol. 336(3), 2004
PMID: 15095982

Export

0 Marked Publications

Open Data PUB

Web of Science

View record in Web of Science®

Sources

PMID: 10978185
PubMed | Europe PMC

Search this title in

Google Scholar